Download presentation
Presentation is loading. Please wait.
Published byYulia Santoso Modified over 5 years ago
1
The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials Matthew A. Rank, MD, John B. Hagan, MD, Miguel A. Park, MD, Jenna C. Podjasek, MD, Shefali A. Samant, MD, Gerald W. Volcheck, MD, Patricia J. Erwin, MLS, Colin P. West, MD, PhD Journal of Allergy and Clinical Immunology Volume 131, Issue 3, Pages e2 (March 2013) DOI: /j.jaci Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig 1 PRISMA flow diagram describing the steps of study selection.4
Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 2 Asthma outcomes in patients who stop or continue ICSs. A, RR ratio of asthma exacerbation in patients who stop or continue ICSs. B, Mean FEV1 difference in patients who stop or continue ICSs. C, Mean morning PEF difference in patients who stop or continue ICSs. D, Standardized mean difference in asthma symptoms in patients who stop or continue ICSs. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.